4
Changes in Ownership
Moleculin Biotech, Inc. Filed Acc 0001437749-26-035617
Chief Financial Officer gave up 10 shares (to pay taxes)
- Chief Financial Officer acquired 41 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Foster Jonathan P. · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-04 | Exercise or conversion : show line 1 in the form | +41 | 20,301 | D | ||
| 2026-11-04 | Shares withheld for taxes : show line 2 in the form | −10 | $8.46 | $85 | 20,291 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-11-04 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −41 | 70,854 | D |
Loading xslF345X06/rdgdoc.xml…